ASCO 2026: Designing the Next Generation of Oncology Trials

At ASCO 2026, Syneos Health is bringing a clear point of view: as oncology evolves, the advantage will go to sponsors who design trials that can act on emerging science and translate innovation into meaningful outcomes for patients, faster. 

Visit us at Booth #21121

Oncology is entering a new phase defined by how effectively that innovation is translated into clinical decision-making and ultimately, into timely access to the right therapies for patients. 

From MRD-driven strategies to complex modalities like ADCs and radiopharmaceuticals, the challenge is no longer discovery. It is designing trials that can operationalize these advances in real-world settings. 

At ASCO, we’re helping sponsors address this shift

Syneos Health integrates translational science, clinical operations and regulatory strategy to support more adaptive, decision-ready trial designs that enable earlier insights, more confident development decisions and faster paths to patients. 

Our oncology model is built to deliver: 

• Effective early phase strategies that align endpoints, biomarkers and trial architecture 
• Site-centered execution through our Catalyst Site Network for faster startup, more predictable enrollment and reduced burden on patients and caregivers through more efficient, accessible trial experiences 
• Cross-functional integration that connects clinical development with commercial and access strategy from the outset 

In today’s environment, generating data alone is insufficient; trial design must support clear clinical decision-making.

Meet with Us at Booth #21121 

Connect with our oncology experts to discuss how to: 

• Integrate minimal residual disease (MRD) and other biomarkers into decision-driven trial design 

• Optimize early phase development across complex modalities 

• Align clinical, operational and regulatory strategy from the start 

Related Content:

Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:  

MRD as a Development Strategy: The Paradigm Shift Reshaping Oncology Trial Design

The Project Optimus Playbook: How to Build Smarter Early Phase Oncology Trials

WEBINAR | Clinical Signals and Strategic Shifts in Oncology